Effects of strontium ranelate administration on bisphosphonate-altered hydroxyapatite: Matrix incorporation of strontium is accompanied by changes in mineralization and microstructure
- PMID: 20654744
- DOI: 10.1016/j.actbio.2010.07.019
Effects of strontium ranelate administration on bisphosphonate-altered hydroxyapatite: Matrix incorporation of strontium is accompanied by changes in mineralization and microstructure
Abstract
Strontium ranelate (SR) is one therapeutic option for reducing risk of fracture in osteoporosis. The effects of SR treatment on hydroxyapatite (HA) previously altered by bisphosphonate (BP) administration remain to be established. Patients who have received long-term BP treatment and present with persistent high fracture risk are of particular interest. Paired iliac crest biopsies from 15 patients post-BP therapy were subjected to a baseline biopsy and a follow-up biopsy after treatment with 2g SR day⁻¹ after either 6 months (n=5) or 12 months (n=10). Dual energy X-ray absorptiometry scans, serum parameters and biochemical markers were obtained. Quantitative backscattered electron imaging and energy-dispersive X-ray analyses combined with micro-X-ray fluorescence determinations were performed to observe any mineralization changes. Static 2-D histomorphometry was carried out to evaluate cellular and structural indices. After 6 months of SR treatment, increases in osteoid surface and strontium content were observed, but no other indices showed significant change. After 12 months of SR treatment, there was a significant increase in bone volume and trabecular thickness, and further increases in strontium content and backscattered signal intensity. These structural changes were accompanied by increased numbers of osteoblasts and increased osteoid surface and volume. Additionally, low bone resorption, as measured by beta-cross-laps, and a low number of osteoclasts were observed. SR treatment led to increased strontium content within the BP-HA nanocomposites and to increased osteoid indices and bone volume, which is indicative of newly formed bone, while osteoclasts were still suppressed. These data points suggest that SR might be considered as a therapeutic option for patients following long-term BP treatment.
Copyright © 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
Comment in
-
[Impacts on bone mineral density].Orthopade. 2014 Feb;43(2):182. Orthopade. 2014. PMID: 24693554 German. No abstract available.
Similar articles
-
Trabecular reorganization in consecutive iliac crest biopsies when switching from bisphosphonate to strontium ranelate treatment.PLoS One. 2011;6(8):e23638. doi: 10.1371/journal.pone.0023638. Epub 2011 Aug 16. PLoS One. 2011. PMID: 21858188 Free PMC article.
-
Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone.J Bone Miner Res. 2005 Sep;20(9):1569-78. doi: 10.1359/JBMR.050405. Epub 2005 Apr 27. J Bone Miner Res. 2005. PMID: 16059629
-
The effect of prior bisphosphonate therapy on the subsequent BMD and bone turnover response to strontium ranelate.J Bone Miner Res. 2010 Mar;25(3):455-62. doi: 10.1359/jbmr.090821. J Bone Miner Res. 2010. PMID: 20201000 Clinical Trial.
-
Strontium ranelate improves bone microarchitecture in osteoporosis.Rheumatology (Oxford). 2009 Oct;48 Suppl 4:iv9-13. doi: 10.1093/rheumatology/kep274. Rheumatology (Oxford). 2009. PMID: 19783592 Review.
-
Improvement in bone strength parameters. The role of strontium ranelate.J Musculoskelet Neuronal Interact. 2007 Jul-Sep;7(3):266-7. J Musculoskelet Neuronal Interact. 2007. PMID: 17947810 Review.
Cited by
-
A physiologically based pharmacokinetic model for strontium exposure in rat.Pharm Res. 2013 Jun;30(6):1536-52. doi: 10.1007/s11095-013-0991-x. Epub 2013 Mar 30. Pharm Res. 2013. PMID: 23543304
-
Strontium ranelate improves post-extraction socket healing in rats submitted to the administration of bisphosphonates.Odontology. 2022 Jul;110(3):467-475. doi: 10.1007/s10266-021-00678-1. Epub 2022 Jan 18. Odontology. 2022. PMID: 35041107
-
High fluoride and low calcium levels in drinking water is associated with low bone mass, reduced bone quality and fragility fractures in sheep.Osteoporos Int. 2014 Jul;25(7):1891-903. doi: 10.1007/s00198-014-2707-4. Epub 2014 Apr 29. Osteoporos Int. 2014. PMID: 24777741 Free PMC article.
-
Strontium ranelate effect on bone mineral density is modified by previous bisphosphonate treatment.Springerplus. 2014 Nov 18;3:676. doi: 10.1186/2193-1801-3-676. eCollection 2014. Springerplus. 2014. PMID: 25520906 Free PMC article.
-
Intrinsic mechanical behavior of femoral cortical bone in young, osteoporotic and bisphosphonate-treated individuals in low- and high energy fracture conditions.Sci Rep. 2016 Feb 16;6:21072. doi: 10.1038/srep21072. Sci Rep. 2016. PMID: 26879146 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials